Effects of lactogen resistance and GH deficiency on mouse metabolism: Pancreatic hormones, adipocytokines, and expression of adiponectin and insulin receptors: Lactogen resistance and GH deficiency in mice

Endocrine

Volumn 32, Issue 2, 2007, Pages 182-191

  Arumugam, Ramamani ^a   Fleenor, Don ^a   Freemark, Michael ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adiponectin; Amylin; Insulin; Interleukin 6; Leptin; Monocyte chemoattractant protein 1; Resistin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; INSULIN RECEPTOR; PANCREAS HORMONE; PROLACTIN; ADIPONECTIN; ADIPONECTIN RECEPTOR; AMYLIN; AMYLOID; CCL2 PROTEIN, MOUSE; GROWTH HORMONE; INSULIN; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE RELEASE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; AGING; ANIMAL; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; METABOLISM; MOUSE MUTANT; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOKINES; ADIPONECTIN; AGING; AMYLOID; ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; FEMALE; GROWTH HORMONE; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; PANCREATIC HORMONES; PROLACTIN; RECEPTOR, INSULIN; RECEPTORS, ADIPONECTIN;

EID: 40349085679     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-007-9017-y     Document Type: Article

References (54)

1. D.E. Fleenor, M. Freemark, Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. Endocrinology 142(7), 2805-2810 (2001)
2. N. Billestrup, J.H. Nielsen, The stimulatory effect of growth hormone, prolactin, and placental lactogen on beta-cell proliferation is not mediated by insulin-like growth factor-I. Endocrinology 129(2), 883-888 (1991)
3. T.C. Brelje, D.W. Scharp, P.E. Lacy et al., Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 132(2), 879-887 (1993)
4. D. Fleenor, A. Petryk, P. Driscoll, M. Freemark, Constitutive expression of placental lactogen in pancreatic beta cells: effects on cell morphology, growth, and gene expression. Pediatr. Res. 47(1), 136-142 (2000)
5. T.D. Brandebourg, J.L. Bown, N. Ben-Jonathan, Prolactin upregulates its receptors and inhibits lipolysis and leptin release in male rat adipose tissue. Biochem. Biophys. Res. Commun. 357(2), 408-413 (2007)
6. P. Berle, Comparative studies on the metabolic effects of some parameters of carbohydrate and lipid metabolism after intravenous administration of human placental lactogen, human prolactin and growth hormone. Acta Endocrinol. Suppl. (Copenh) 173, 104 (1973)
7. D.J. Flint, N. Binart, J. Kopchick, P. Kelly, Effects of growth hormone and prolactin on adipose tissue development and function. Pituitary 6(2), 97-102 (2003)
8. P.J. Fielder, F. Talamantes, The lipolytic effects of mouse placental lactogen II, mouse prolactin, and mouse growth hormone on adipose tissue from virgin and pregnant mice. Endocrinology 121(2), 493-497 (1987)
9. J.P. Felber, N. Zaragoza, M. Benuzzi-Badoni, A.R. Genazzani, The double effect of human chorionic somatomammotropin (HCS) and pregnancy on lipogenesis and on lipolysis in the isolated rat epididymal fat pad and fat pad cells. Horm. Metab. Res. 4(4), 293-296 (1972)
10. C. Ling, G. Hellgren, M. Gebre-Medhin et al., Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation and in PRL-transgenic mice. Endocrinology 141(10), 3564-3572 (2000)
11. F.M. Reis, A.M. Reis, C.C. Coimbra, Effects of hyperprolactinaemia on glucose tolerance and insulin release in male and female rats. J. Endocrinol. 153(3), 423-428 (1997)
12. E.A. Ryan, L. Enns, Role of gestational hormones in the induction of insulin resistance. J. Clin. Endocrinol. Metab. 67(2), 341-347 (1988)
13. J.R. Turtle, D.M. Kipnis, The lipolytic action of human placental lactogen on isolated fat cells. Biochim. Biophys. Acta 144(3), 583-593 (1967)
14. A. Tuzcu, M. Bahceci, M. Dursun, C. Turgut, S. Bahceci, Insulin sensitivity and hyperprolactinemia. J. Endocrinol. Invest. 26(4), 341-346 (2003)
15. D. Yavuz, O. Deyneli, I. Akpinar et al., Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women. Eur. J. Endocrinol. 149(3), 187-193 (2003)
16. G. Schernthaner, R. Prager, C. Punzengruber, A. Luger, Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo. Diabetologia 28(3), 138-142 (1985)
17. M. Freemark, The Roles of Growth Hormone, Prolactin and Placental Lactogen in Human Fetal Development:Critical Analysis of Molecular, Cellular and Clinical Investigations (Humana Press, Totowa, NJ, 1999)
18. D. Fleenor, J. Oden, P.A. Kelly et al., Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology 146(1), 103-112 (2005)
19. P.H. Black, The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav. Immun. 17(5), 350-364 (2003)
20. P.E. Scherer, Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55(6), 1537-1545 (2006)
21. A.R. Nawrocki, M.W. Rajala, E. Tomas et al., Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 281(5), 2654-2660 (2006)
22. A.J. McAinch, G.R. Steinberg, J. Mollica et al., Differential regulation of adiponectin receptor gene expression by adiponectin and leptin in myotubes derived from obese and diabetic individuals. Obesity (Silver Spring) 14(11), 1898-1904 (2006)
23. G.D. Tan, C. Debard, T. Funahashi et al., Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy. Diabetologia 48(8), 1585-1589 (2005)
24. D.P. Argentino, F.P. Dominici, K. Al-Regaiey, M.S. Bonkowski, A. Bartke, D. Turyn, Effects of long-term caloric restriction on early steps of the insulin-signaling system in mouse skeletal muscle. J. Gerontol. A Biol. Sci. Med. Sci. 60(1), 28-34 (2005)
25. L.R. Donahue, W.G. Beamer, Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J. Endocrinol. 136(1), 91-104 (1993)
26. N. Moller, J. Gjedsted, L. Gormsen, J. Fuglsang, C. Djurhuus, Effects of growth hormone on lipid metabolism in humans Growth Horm. IGF Res. 13(Suppl A), S18-21 (2003)
27. C. Ling, L. Svensson, B. Oden et al., Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue. J. Clin. Endocrinol. Metab. 88(4), 1804-1808 (2003)
28. N. Moller, H. Norrelund, The role of growth hormone in the regulation of protein metabolism with particular reference to conditions of fasting. Horm. Res. 59(Suppl 1), 62-68 (2003)
29. R.L. Hull, G.T. Westermark, P. Westermark, S.E. Kahn, Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J. Clin. Endocrinol. Metab. 89(8), 3629-3643 (2004)
30. A. Young, Effects in skeletal muscle. Adv. Pharmacol. 52, 209-228 (2005)
31. Y.S.J. Gui, L.J. Murphy, Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes. Res. 12, 1481-1491 (2004)
32. F.P. Dominici, G. Arostegui Diaz, A. Bartke, J.J. Kopchick, D. Turyn, Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. J. Endocrinol. 166(3), 579-590 (2000)
33. F.P. Dominici, S. Hauck, D.P. Argentino, A. Bartke, D. Turyn, Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice. J. Endocrinol. 173(1), 81-94 (2002)
34. F.P. Dominici, D.P. Argentino, A. Bartke, D. Turyn, The dwarf mutation decreases high dose insulin responses in skeletal muscle, the opposite of effects in liver. Mech. Ageing Dev. 124(7), 819-827 (2003)
35. L. Nilsson, N. Binart, Y.M. Bohlooly et al., Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem. Biophys. Res. Commun. 331(4), 1120-1126 (2005)
36. J.J. Senn, P.J. Klover, I.A. Nowak, R.A. Mooney, Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51(12), 3391-3399 (2002)
37. P.J. Klover, A.H. Clementi, R.A. Mooney, Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146(8), 3417-3427 (2005)
38. H.J. Kim, T. Higashimori, S.Y. Park et al., Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes. 53(4), 1060-1067 (2004)
39. C. Lambillotte, P. Gilon, J.C. Henquin, Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J. Clin. Invest. 99(3), 414-423 (1997)
40. Y. Qi, Z. Nie, Y.S. Lee et al., Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 55(11), 3083-3090 (2006)
41. J.V. Silha, H.A. Weiler, L.J. Murphy, Plasma adipokines and body composition in response to modest dietary manipulations in the mouse. Obesity (Silver Spring) 14(8), 1320-1329 (2006)
42. M. Maebuchi, M. Machidori, R. Urade, T. Ogawa, T. Moriyama, Low resistin levels in adipose tissues and serum in high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin. Arch. Biochem. Biophys. 416(2), 164-170 (2003)
43. C.C. Hsieh, J.H. DeFord, K. Flurkey, D.E. Harrison, J. Papaconstantinou, Effects of the Pit1 mutation on the insulin signaling pathway: implications on the longevity of the long-lived Snell dwarf mouse. Mech. Ageing Dev. 123(9), 1245-1255 (2002)
44. C.C. Hsieh, J.H. DeFord, K. Flurkey, D.E. Harrison, J. Papaconstantinou, Implications for the insulin signaling pathway in Snell dwarf mouse longevity: a similarity with the C. elegans longevity paradigm. Mech. Ageing Dev. 123(9), 1229-1244 (2002)
45. K. Flurkey, J. Papaconstantinou, R.A. Miller, D.E. Harrison, Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl. Acad. Sci. USA 98(12), 6736-6741 (2001)
46. M.L. Heiman, F.C. Tinsley, J.A. Mattison, S. Hauck, A. Bartke, Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice. Endocrine 20(1-2), 149-154 (2003)
47. D.J. Flint, N. Binart, S. Boumard, J.J. Kopchick, P. Kelly, Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity. J. Endocrinol. 191(1), 101-111 (2006)
48. M. Freemark, D. Fleenor, P. Driscoll, N. Binart, P. Kelly, Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 142(2), 532-537 (2001)
49. M. Freemark, I. Avril, D. Fleenor et al., Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology 143(4), 1378-1385 (2002)
50. P. Godfrey, J.O. Rahal, W.G. Beamer, N.G. Copeland, N.A. Jenkins, K.E. Mayo, GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat. Genet. 4(3), 227-232 (1993)
51. C.J. Ormandy, A. Camus, J. Barra et al., Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11(2), 167-178 (1997)
52. D. Fleenor, R. Arumugam, M. Freemark, Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm. Res. 66(3), 101-110 (2006)
53. R. Arumugam, D. Fleenor, M. Freemark, Lactogenic and somatogenic hormones regulate the expression of neuropeptide Y and cocaine- and amphetamine- regulated transcript in rat insulinoma (INS-1) cells: interactions with glucose and glucocorticoids. Endocrinology 148(1), 258-267 (2007)
54. K. Dheda, J.F. Huggett, S.A. Bustin, M.A. Johnson, G. Rook, A. Zumla, Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 37(1), 112-114, 116, 118-119 (2004)